Stocks
Nuwellis, Inc.NUWE
NASDAQManufacturingMedical Devices$0.32
Price as of · delayed, not real-time
A medical device maker focused on treating fluid overload in hospitalized patients, including those with heart failure and kidney disease. Its proprietary ultrafiltration therapy offers an alternative to diuretics, and the company is working to expand adoption in acute care settings. Investors track Nuwellis for its potential in the growing fluid management market and its recent commercialization efforts.
52W Range: $0.32-$172.90
Congressional Interest in Nuwellis, Inc. (NUWE)
No congressional trades have been disclosed for Nuwellis, Inc. (NUWE) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading NUWE?
No congressional trades found for this stock.